Ionic Capital Management’s Pfizer PFE Stock Holding History

Ionic Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-60,400	Closed	-$3.09M	–	378
2022 Q4	$3.09M	Hold	60,400	–	–	0.73%	39
2022 Q3	$2.64M	Buy	+60,400	New	+$2.93M	0.36%	85
2018 Q2	–	Sell	-31,620	Closed	-$1.06M	–	264
2018 Q1	$1.06M	Hold	31,620	–	–	0.07%	167
2017 Q4	$1.09M	Sell	31,620 -94,860	-75%	-$3.23M	0.05%	236
2017 Q3	$4.28M	Buy	126,480 +48,906	+63%	+$1.57M	0.17%	119
2017 Q2	$2.47M	Buy	+77,574	New	+$2.45M	0.13%	155
2017 Q1	–	Sell	-47,430	Closed	-$1.46M	–	362
2016 Q4	$1.46M	Buy	+47,430	New	+$1.45M	0.08%	217
2016 Q1	–	Sell	-79,050	Closed	-$2.42M	–	343
2015 Q4	$2.42M	Sell	79,050 -228,718	-74%	-$7.2M	0.17%	133
2015 Q3	$9.17M	Buy	307,768 +121,210	+65%	+$3.89M	0.5%	60
2015 Q2	$5.93M	Sell	186,558 -24,242	-12%	-$790K	0.28%	76
2015 Q1	$6.96M	Buy	+210,800	New	+$6.7M	0.27%	94
2014 Q3	–	Sell	-105,400	Closed	-$2.97M	–	252
2014 Q2	$2.97M	Buy	+105,400	New	+$3M	0.1%	135
2013 Q3	–	Sell	-63,240	Closed	-$1.68M	–	271
2013 Q2	$1.68M	Buy	+63,240	New	+$1.75M	0.05%	199

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ionic Capital Management's PFE Position: Q1 2024 in Review

Ionic Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 11,500 shares — an estimated $319K sold.

Ionic Capital Management first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $4.24M in Q3 2015. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Ionic Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Ionic Capital Management sold 11,500 Pfizer shares in Q1 2024, an estimated $319K.
Ionic Capital Management first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
Ionic Capital Management's Pfizer position peaked at $4.24M in Q3 2015.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Ionic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.